Medical and Pharmaceutical AI-powered lung cancer detection debuts at Topeka’s St. Francis Hospital The program aims to prevent overlooked findings, surface patients who need additional review, and support long-term monitoring Joseph Morton3 days ago
Medical and Pharmaceutical Nuvation Bio stock climbs 16.67% on FDA approval of lung cancer drug The approval marked a pivotal milestone for the company, transitioning it from a clinical-stage entity to a commercial-stage player Joseph MortonSeptember 5, 2025
Medical and Pharmaceutical Communities unite to fund cancer care and research Proceeds from the tournament are funding advanced AI imaging software for mammography Joseph MortonSeptember 2, 2025
AI and Autonomy Moffitt adopts PathAI AISight Dx to drive cancer care innovation The partnership establishes a framework for joint research initiatives, real-world data collection, and clinical trial support Joseph MortonAugust 27, 2025
Health & Wellness University of Kentucky mobile cancer clinic enables diagnosis and treatment in a single visit The ability to confirm and treat cancer in the same day lets patients get an answer immediately Joseph MortonAugust 19, 2025
Medical and Pharmaceutical Fighting cancer is a global initiative: new report Cancer diagnostics encompass a wide range of tests and technologies used to detect cancer Joseph MortonAugust 12, 2025
Medical and Pharmaceutical Puma Biotechnology shares get favourable price bump on strong Q2 results The absence of negative developments over the past month has helped sentiment recover Joseph MortonAugust 11, 2025
Health & Wellness New Fraunhofer technology promises lower radiation in cancer imaging Radar technology has long played a vital role in aviation and automotive industries Joseph MortonAugust 6, 2025
AI and Autonomy Offline AI tool could transform skin cancer diagnosis in remote areas Ensuring the system's resilience in low-resource environments has been a core design priority Joseph MortonJuly 30, 2025
Medical and Pharmaceutical Medpace Holdings stock just popped by 50%, but why? Medpace delivered a standout Q2, with revenue rising 14.2 per cent year-over-year to USD$603.3 million Joseph MortonJuly 22, 2025